// App-Quantinova.ai

62 : Evaluation of PTEN status in circulating tumor cells (CTCs) and matched tumor tissue from patients with castrate-resistant prostate cancer (CRPC).

Researchers

Presenter

  • Elizabeth Punnoose

Principal Investigators

  • Eric Tucker

  • Dena Marrinucci

  • Lukas C. Amler

  • Hartmut Koeppen

  • Premal H. Patel

  • Yibing Yan

  • Ruth Riisnaes

  • Gerhardt Attard

  • Johann Sebastian De Bono

Medical Centers

  • Institute for Cancer Research, London, United Kingdom

  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  • Epic Sciences, Inc., La Jolla, CA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Phosphatase and tensin homolog

  • Circulating tumor cells

  • Cluster of differentiation 45

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved